Unknown

Dataset Information

Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer.


ABSTRACT:

SUBMITTER: Corti C 

PROVIDER: S-EPMC8103530 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets